Copyright
©The Author(s) 2004.
World J Gastroenterol. May 15, 2004; 10(10): 1387-1391
Published online May 15, 2004. doi: 10.3748/wjg.v10.i10.1387
Published online May 15, 2004. doi: 10.3748/wjg.v10.i10.1387
Figure 3 Western blot analysis of expression of multiple forms of clusterin in ESCC.
nCLU: the nonglycosylated uncleaved nuclear clusterin; α/β CLU: cleaved and glycosylated secreted clusterin protein; β CLU: cleaved and glycosylated clusterin β chain; B-5: monoclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA) reacted with the C-terminus of clusterin-β of human origin and did not react with the nuclear clusterin; H-330: polyclonal antibody (Santa Cruz Biotechnology, Santa Cruz, CA) recognized the major part of clusterin from 120 to 449 aa at the C-terminus of clusterin-α/β chains including unleaved nuclear clusterin (-50 ku and the matured secreted clusterin (-37-40 ku); Np: pooled normal esophageal mucosa from 10 cases; Cp: pooled ESCC tumor tissues from 10 cases; N109: normal esophageal mucosa from a single individual; C109: ESCC tumor tissue from a single individual. β-actin was used as loading control.
- Citation: He HZ, Song ZM, Wang K, Teng LH, Liu F, Mao YS, Lu N, Zhang SZ, Wu M, Zhao XH. Alterations in expression, proteolysis and intracellular localizations of clusterin in esophageal squamous cell carcinoma. World J Gastroenterol 2004; 10(10): 1387-1391
- URL: https://www.wjgnet.com/1007-9327/full/v10/i10/1387.htm
- DOI: https://dx.doi.org/10.3748/wjg.v10.i10.1387